Sun Pharma Executive and Leadership Team

Lisa Khan, the Chief Executive Officer at Sun Pharma, directs the overarching corporate strategy and operational execution for the global pharmaceutical enterprise. Overseeing all major business units, Khan ensures alignment with the company's mission to provide high-quality specialty generic pharmaceuticals and active pharmaceutical ingredients. This leadership position involves driving market expansion and optimizing resource allocation across diverse geographical regions. By fostering a culture of innovation and efficiency, Lisa Khan guides the company's trajectory in the competitive pharmaceutical landscape, focusing on sustainable growth and enhanced patient access to essential medicines. The Chief Executive Officer's purview encompasses all strategic initiatives, ensuring the company's long-term viability and market leadership.

Kal Sundaram, the Chief Executive Officer, America' at Sun Pharma, directs all strategic and operational activities across the North and South American markets. Sundaram is responsible for driving business growth, expanding market share for pharmaceutical formulations and active pharmaceutical ingredients, and ensuring the company's robust presence in the region. This leadership role involves overseeing sales, marketing, and distribution networks, adapting global strategies to meet the specific demands of the American pharmaceutical landscape. By fostering key partnerships and optimizing regional operations, Kal Sundaram ensures Sun Pharma's continued success and commitment to patient access throughout the Americas. The Chief Executive Officer, America's focus is on maximizing regional performance and strategic development.

Jayashree Satagopan, the Global Chief Financial Officer at Sun Pharma, manages the company's comprehensive financial operations and strategic fiscal planning worldwide. Satagopan oversees all aspects of financial reporting, budgeting, and investment, ensuring robust fiscal health and driving profitability for the pharmaceutical manufacturer. This critical role involves optimizing capital allocation, managing risk, and identifying opportunities for financial growth in both established and emerging markets. By providing strategic financial insights, Jayashree Satagopan supports the company's expansion in specialty generics and active pharmaceutical ingredients. The Global Chief Financial Officer's expertise is essential for maintaining financial stability and enabling Sun Pharma's continued investment in research and development.

Zvi Albert, the Chief Financial Officer (North America) at Sun Pharma, oversees the financial strategy and operations for the company's significant North American business segment. Albert manages all financial planning, analysis, and reporting activities, ensuring fiscal discipline and driving profitability within the region. This role is crucial for supporting the growth and expansion of Sun Pharma's pharmaceutical formulations and active pharmaceutical ingredients across the United States and Canada. By providing strategic financial guidance, Zvi Albert enables informed decision-making and optimizes resource allocation to capitalize on market opportunities. The Chief Financial Officer (North America)'s leadership ensures the financial health and strategic alignment of the company's regional endeavors.

Akshay Sethi, the Group Chief Financial Officer at Sun Pharma, provides executive financial leadership across the entire global organization. Sethi oversees the consolidated financial performance, strategic financial planning, and capital management for Sun Pharma's diverse operations, including the manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. This role involves ensuring financial transparency, optimizing investment strategies, and driving operational efficiencies to support sustained growth. By guiding financial policy and risk management, Akshay Sethi plays a pivotal part in maintaining the company's financial integrity and enabling its strategic expansion into new therapeutic areas and markets. The Group Chief Financial Officer's oversight is fundamental to Sun Pharma's global financial strategy.

Darshita Shah, the Quality Assurance Specialist & Chief Marketing Officer I ( Compliance) at Sun Pharma, spearheads critical compliance initiatives and oversees marketing strategies for specific product segments. Shah ensures adherence to stringent global regulatory standards across all manufacturing and distribution processes, safeguarding product integrity and patient safety. Simultaneously, this dual role involves developing and executing targeted marketing campaigns that resonate with healthcare professionals and consumers, particularly within compliance-driven markets. The focus remains on maintaining the highest quality benchmarks while driving market penetration for Sun Pharma's pharmaceutical formulations and active pharmaceutical ingredients. Darshita Shah's leadership ensures that both product quality and market presence meet rigorous industry expectations.

Faried Niamut, the Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded at Sun Pharma, leads dual critical functions within the organization. Niamut ensures the highest standards of quality assurance for the company's biologics and branded pharmaceutical products, maintaining strict compliance with all regulatory requirements. Concurrently, this executive develops and executes innovative marketing strategies tailored to the unique dynamics of the biologics and branded pharmaceutical sectors. The focus is on enhancing market penetration and brand visibility for these specialized product lines. Faried Niamut's integrated approach guarantees both product integrity and effective market positioning, supporting Sun Pharma's diverse portfolio.

Jaydeep Shah, the Chief Marketing Officer, Consumer Health Business, Sun Pharma, directs the strategic marketing initiatives for Sun Pharma's consumer health product portfolio. Shah is responsible for developing and implementing comprehensive marketing plans designed to increase brand awareness, drive sales, and enhance market penetration for over-the-counter pharmaceuticals and wellness products. This leadership position involves understanding consumer needs, identifying market trends, and leveraging digital and traditional channels to connect with target audiences effectively. By fostering strong brand equity, Jaydeep Shah ensures the continued growth and success of Sun Pharma's consumer health offerings, reinforcing the company's commitment to accessible healthcare solutions.

Cynthia Meiners, the Healthcare Executive at Sun Pharma, contributes extensive expertise to the company's strategic direction within the healthcare sector. Meiners focuses on advancing Sun Pharma's mission to deliver high-quality pharmaceutical formulations and active pharmaceutical ingredients to patients globally. This role involves identifying key opportunities for growth, fostering strategic alliances, and ensuring that the company's operations align with evolving healthcare needs and market dynamics. By leveraging deep industry knowledge, Cynthia Meiners supports the development and execution of initiatives that enhance patient access and therapeutic outcomes. The Healthcare Executive's contributions are vital to Sun Pharma's ongoing commitment to innovation and market leadership.

Marianela Echeverry, the Rrhh at Sun Pharma, manages critical human resources functions essential for the company's operational success. Echeverry oversees talent acquisition, employee development, and organizational culture initiatives, ensuring a skilled and motivated workforce across Sun Pharma's global operations. This role is fundamental to supporting the company's manufacturing and distribution of pharmaceutical formulations and active pharmaceutical ingredients by cultivating a high-performing team. By championing employee engagement and fostering a supportive work environment, Marianela Echeverry contributes directly to Sun Pharma's ability to innovate and achieve its strategic objectives. The Rrhh's focus is on building and maintaining a robust organizational infrastructure.